Global Cystoid Macular Edema Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 1883

Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disruption of the normal blood-retinal barrier which leads to leakage from the perifoveal retinal capillaries causing accumulation of fluid within the intracellular spaces of the retina, mainly in the outer plexiform layer. CME is of two types: pseudophakic and nonpseudophakic cystoid macular edema. Pseudophakic cystoids macular edema is when the cause of occurrence is known while nonpseudophakic is the condition where no specific clinical findings have been observed. Symptoms of cystoids macular edema are blurred or decreased central vision.
The cause of CME is not completely known though it may be accompanied by various diseases such as uveitis, vein occlusion or diabetes. It is also known to occur commonly after cataract surgery. Various risk factors associated with cystoids macular edema are penetrating keratoplasty (corneal transplant), retinal surgery, chronic renal failure, retinal vein occlusion, retinitis pigmentosa, systemic medication and topical prostaglandin analogs for glaucoma..No significant racial or sex related predilection exists for this condition. However, cystoids macular edema can occur at any age based on the etiology, though advanced age is at higher risk.
In 2018, the global Cystoid Macular Edema market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cystoid Macular Edema status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cystoid Macular Edema development in United States, Europe and China.

The key players covered in this study
EMMES
Fovea Pharmaceuticals
Icon Bioscience
Merck
Sanwa Kagaku Kenkyusho
Novartis
Johns Hopkins University
Wake Forest University
Iladevi Cataract
IOL Research Center
Rabin Medical Center
Kyushu University
Wills Eye Institute

Market segment by Type, the product can be split into
Non Steroidal Anti-Inflammatory Drugs
Anti- Vascular Endothelial Growth Factor (VEGF) Agents
Carbonic Anhydrase Inhibitors
Steroids

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cystoid Macular Edema status, future forecast, growth opportunity, key market and key players.
To present the Cystoid Macular Edema development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cystoid Macular Edema are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cystoid Macular Edema Market Size Growth Rate by Type (2014-2025)
1.4.2 Non Steroidal Anti-Inflammatory Drugs
1.4.3 Anti- Vascular Endothelial Growth Factor (VEGF) Agents
1.4.4 Carbonic Anhydrase Inhibitors
1.4.5 Steroids
1.5 Market by Application
1.5.1 Global Cystoid Macular Edema Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cystoid Macular Edema Market Size
2.2 Cystoid Macular Edema Growth Trends by Regions
2.2.1 Cystoid Macular Edema Market Size by Regions (2014-2025)
2.2.2 Cystoid Macular Edema Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cystoid Macular Edema Market Size by Manufacturers
3.1.1 Global Cystoid Macular Edema Revenue by Manufacturers (2014-2019)
3.1.2 Global Cystoid Macular Edema Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cystoid Macular Edema Market Concentration Ratio (CR5 and HHI)
3.2 Cystoid Macular Edema Key Players Head office and Area Served
3.3 Key Players Cystoid Macular Edema Product/Solution/Service
3.4 Date of Enter into Cystoid Macular Edema Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cystoid Macular Edema Market Size by Type (2014-2019)
4.2 Global Cystoid Macular Edema Market Size by Application (2014-2019)

5 United States
5.1 United States Cystoid Macular Edema Market Size (2014-2019)
5.2 Cystoid Macular Edema Key Players in United States
5.3 United States Cystoid Macular Edema Market Size by Type
5.4 United States Cystoid Macular Edema Market Size by Application

6 Europe
6.1 Europe Cystoid Macular Edema Market Size (2014-2019)
6.2 Cystoid Macular Edema Key Players in Europe
6.3 Europe Cystoid Macular Edema Market Size by Type
6.4 Europe Cystoid Macular Edema Market Size by Application

7 China
7.1 China Cystoid Macular Edema Market Size (2014-2019)
7.2 Cystoid Macular Edema Key Players in China
7.3 China Cystoid Macular Edema Market Size by Type
7.4 China Cystoid Macular Edema Market Size by Application

8 Japan
8.1 Japan Cystoid Macular Edema Market Size (2014-2019)
8.2 Cystoid Macular Edema Key Players in Japan
8.3 Japan Cystoid Macular Edema Market Size by Type
8.4 Japan Cystoid Macular Edema Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cystoid Macular Edema Market Size (2014-2019)
9.2 Cystoid Macular Edema Key Players in Southeast Asia
9.3 Southeast Asia Cystoid Macular Edema Market Size by Type
9.4 Southeast Asia Cystoid Macular Edema Market Size by Application

10 India
10.1 India Cystoid Macular Edema Market Size (2014-2019)
10.2 Cystoid Macular Edema Key Players in India
10.3 India Cystoid Macular Edema Market Size by Type
10.4 India Cystoid Macular Edema Market Size by Application

11 Central & South America
11.1 Central & South America Cystoid Macular Edema Market Size (2014-2019)
11.2 Cystoid Macular Edema Key Players in Central & South America
11.3 Central & South America Cystoid Macular Edema Market Size by Type
11.4 Central & South America Cystoid Macular Edema Market Size by Application

12 International Players Profiles
12.1 EMMES
12.1.1 EMMES Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cystoid Macular Edema Introduction
12.1.4 EMMES Revenue in Cystoid Macular Edema Business (2014-2019)
12.1.5 EMMES Recent Development
12.2 Fovea Pharmaceuticals
12.2.1 Fovea Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cystoid Macular Edema Introduction
12.2.4 Fovea Pharmaceuticals Revenue in Cystoid Macular Edema Business (2014-2019)
12.2.5 Fovea Pharmaceuticals Recent Development
12.3 Icon Bioscience
12.3.1 Icon Bioscience Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cystoid Macular Edema Introduction
12.3.4 Icon Bioscience Revenue in Cystoid Macular Edema Business (2014-2019)
12.3.5 Icon Bioscience Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cystoid Macular Edema Introduction
12.4.4 Merck Revenue in Cystoid Macular Edema Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Sanwa Kagaku Kenkyusho
12.5.1 Sanwa Kagaku Kenkyusho Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cystoid Macular Edema Introduction
12.5.4 Sanwa Kagaku Kenkyusho Revenue in Cystoid Macular Edema Business (2014-2019)
12.5.5 Sanwa Kagaku Kenkyusho Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cystoid Macular Edema Introduction
12.6.4 Novartis Revenue in Cystoid Macular Edema Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 Johns Hopkins University
12.7.1 Johns Hopkins University Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cystoid Macular Edema Introduction
12.7.4 Johns Hopkins University Revenue in Cystoid Macular Edema Business (2014-2019)
12.7.5 Johns Hopkins University Recent Development
12.8 Wake Forest University
12.8.1 Wake Forest University Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cystoid Macular Edema Introduction
12.8.4 Wake Forest University Revenue in Cystoid Macular Edema Business (2014-2019)
12.8.5 Wake Forest University Recent Development
12.9 Iladevi Cataract
12.9.1 Iladevi Cataract Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cystoid Macular Edema Introduction
12.9.4 Iladevi Cataract Revenue in Cystoid Macular Edema Business (2014-2019)
12.9.5 Iladevi Cataract Recent Development
12.10 IOL Research Center
12.10.1 IOL Research Center Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cystoid Macular Edema Introduction
12.10.4 IOL Research Center Revenue in Cystoid Macular Edema Business (2014-2019)
12.10.5 IOL Research Center Recent Development
12.11 Rabin Medical Center
12.12 Kyushu University
12.13 Wills Eye Institute

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details